Onconomics Extracts+ Advanced Analysis for Natural Substances
Drug efficacy
Identify natural compounds for an integrative cancer treatment
Onconomics Extracts+ is an extension of the Onconomics Extracts test. This advanced test provides detailed insights into the effectiveness of natural substances and plant extracts as anticancer agents. By analyzing how specific natural compounds interact with cancer cells, Onconomics Extracts+ helps identify the most promising natural treatment options for each patient to support an integrative cancer treatment.
Compared to RGCC’s Onconomics Extracts test, this test includes a comprehensive gene expression analysis, examining how key genes behave within the patient’s cancer cells.
The test result creates a personalized profile that reveals how the cancer develops and responds within the body, helping clinicians make informed, evidence-based decisions about natural and complementary treatments.
The Onconomics Extracts+ test provides information about the following:
Circulating tumor cell (CTC) count
Gene expressions of the patient’s cancer cells
Effectiveness of 50+ natural substances and plant extracts on the patient’s cancer cells
Resistance factor of the cancer cells
How does the Onconomics Extracts+ test work?
Circulating tumor cells are isolated from the patient’s peripheral blood sample and then used for different assays. The results provide a comprehensive and highly personalized analysis of the most effective natural treatments that patients can use to treat their cancer, alongside conventional therapies.
The cancer blood test analyzes the effectiveness of 50+ natural substances and plant extracts on the patient’s cancer cells. The tested substances are divided into 3 classes as follows:
Class I: Cytotoxic agents
Class II: Immunostimulants
Class III: PK inhibitors
To evaluate the effectiveness of anti-cancer drugs, learn more about the Onconomics test or the Onconomics Plus test for a combined and comprehensive evaluation.
Who should get an Onconomics Extracts+ test?
Onconomics Extracts+ is useful for cancer patients who have exhausted their chemotherapeutic options and/or want to explore a non-chemotherapeutic approach by including evidence-based natural substance options.
Test details
Sample type
Blood or tissue sample (Tissue for CNS Primary Tumors)
Analysis period
≈ 7 business days
Cancer type
Applicable for all cancer types
Final results
7-10 business days after sample delivery
Sample size
15-25 ml of peripheral whole blood. Tissue sample: Minimum 400mg.
Price*
1750 €
* The prices of the tests may be an issue of local additional taxes and value added taxes which are dependent of each country’s legislation. The prices may vary in areas that are under the jurisdiction of a distributor. These prices are for the tests only, and they do not include in-office fees such as consultation, blood draws, etc.
* RGCC is not liable for any third-party comments or claims regarding our products. For accurate and up-to-date information about our offerings, please refer to our official website: rgcc-international.com
